Andersons pediatric cardiology 1479

andthemechanismofdilatation.BrHeartJ.
1988;60(4):299–308.
63.PadialLR,etal.Echocardiographycanpredict
whichpatientswilldevelopseveremitral
regurgitationafterpercutaneousmitral
valvulotomy.JAmCollCardiol.
1996;27(5):1225–1231.
64.NunesMC,etal.Theechoscorerevisited:
impactofincorporatingcommissural
morphologyandleafletdisplacementtothe
predictionofoutcomeforpatientsundergoing
percutaneousmitralvalvuloplasty.Circulation.
2014;129(8):886–895.
65.ShawTR,NorthridgeDB,SutariaN.Mitral
balloonvalvotomyandleftatrialthrombus.
Heart.2005;91(8):1088–1089.
66.ManjunathCN,etal.Balloonmitralvalvotomy
inpatientswithmitralstenosisandleftatrial
thrombus.CatheterCardiovascInterv.
2009;74(4):653–661.
67.InoueK,etal.Clinicalapplicationoftransvenous
mitralcommissurotomybyanewballoon
catheter.JThoracCardiovascSurg.
1984;87(3):394–402.
68.AlZaibagM,etal.Percutaneousdouble-balloon
mitralvalvotomyforrheumaticmitral-valve
stenosis.Lancet.1986;1(8484):757–761.


69.BonhoefferP,etal.Mitraldilatationwiththe
Multi-tracksystem:analternativeapproach.

CathetCardiovascDiagn.1995;36(2):189–193.
70.CribierA,etal.Percutaneousmechanicalmitral
commissurotomywithanewlydesignedmetallic
valvulotome:immediateresultsoftheinitial
experiencein153patients.Circulation.
1999;99(6):793–799.
71.PalaciosI,SilvaG.Interventions.SievertH,etal.
Structural,Valvular,andCongenitalHeart
Disease.CRCPress;2015.
72.RemenyiB,etal.Valvularaspectsofrheumatic
heartdisease.Lancet.2016;387(10025):1335–
1346.
73.BaumgartnerH,etal.2017ESC/EACTS
guidelinesforthemanagementofvalvularheart
disease:thetaskforceforthemanagementof
valvularheartdiseaseoftheEuropeansocietyof
cardiology(ESC)andtheEuropeanassociation
forCardio-thoracicsurgery(EACTS).EurHeart
J.2017.
74.ChikweJ,etal.Relationofmitralvalvesurgery
volumetorepairrate,Durability,andsurvival.J
AmCollCardiol.2017.
75.DangasGD,etal.Prostheticheartvalve
thrombosis.JAmCollCardiol.
2016;68(24):2670–2689.


76.YacoubMH,CohnLH.Novelapproachesto
cardiacvalverepair:fromstructuretofunction:
partI.Circulation.2004;109(8):942–950.

77.TsakirisAG,etal.Relationofmitralvalve
openingandclosuretoleftatrialandventricular
pressuresintheintactdog.AmJPhysiol.
1978;234(2):H146–H151.
78.RozichJD,etal.Mitralvalvereplacementwith
andwithoutchordalpreservationinpatientswith
chronicmitralregurgitation.Mechanismsfor
differencesinpostoperativeejection
performance.Circulation.1992;86(6):1718–
1726.
79.SadlerL,etal.Pregnancyoutcomesandcardiac
complicationsinwomenwithmechanical,
bioprostheticandhomograftvalves.BJOG.
2000;107(2):245–253.
80.McLintockC.Anticoagulantchoicesinpregnant
womenwithmechanicalheartvalves:balancing
maternalandfetalrisks–thedifferencethedose
makes.ThrombRes.2013;131(suppl1):S8–S10.
81.CheungDY,DuanB,ButcherJT.Current
progressintissueengineeringofheartvalves:
multiscaleproblems,multiscalesolutions.
ExpertOpinBiolTher.2015;15(8):1155–1172.
82.BattenP,etal.Humanmesenchymalstemcells
induceTcellanergyanddownregulateTcell